Photodynamic therapy of DNA mismatch repair-deficient and -proficient tumour cells
2002

Photodynamic Therapy and DNA Mismatch Repair in Tumor Cells

publication Evidence: moderate

Author Information

Author(s): Schwarz V A, Hornung R, Fedier A, Fehr M K, Walt H, Haller U, Fink D

Primary Institution: University Hospital of Zurich

Hypothesis

Does loss of DNA mismatch repair affect the sensitivity of tumor cells to photodynamic therapy?

Conclusion

Photodynamic therapy is effective in both DNA mismatch repair-deficient and proficient tumor cells, and does not lead to loss of mismatch repair.

Supporting Evidence

  • Loss of DNA mismatch repair does not lead to resistance to photodynamic therapy.
  • Repeated exposure to photodynamic therapy does not result in loss of DNA mismatch repair proteins.
  • Both MMR-deficient and proficient cells showed similar drug uptake kinetics.

Takeaway

This study shows that a new treatment called photodynamic therapy works just as well on cancer cells that have a specific DNA repair problem as it does on normal cells.

Methodology

The study tested the sensitivity of various tumor cell lines to photodynamic therapy using a specific photosensitizer and assessed cell survival through clonogenic assays.

Limitations

The study primarily focuses on in vitro experiments, which may not fully represent in vivo conditions.

Statistical Information

P-Value

p=0.57

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.1038/sj.bjc.6600218

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication